Holger G. Hass

Cetuximab Plus Capecitabine and Irinotecan Compared With Cetuximab Plus Capecitabine and Oxaliplatin As First-Line Treatment for Patients With Metastatic Colorectal Cancer: AIO KRK-0104—A Randomized Trial of the German AIO CRC Study Group

Nicolas Moosmann, Ludwig Fischer von Weikersthal, Ursula Vehling‐Kaiser et al. · Journal of Clinical Oncology · 2011 · 117 citations

Medicine, Oncology, Pharmacology +14

Left-sided primary tumors are associated with favorable prognosis in patients with KRAS codon 12/13 wild-type metastatic colorectal cancer treated with cetuximab plus chemotherapy: an analysis of the AIO KRK-0104 trial

Jobst C. von Einem, Volker Heinemann, Ludwig Fischer von Weikersthal et al. · Journal of Cancer Research and Clinical Oncology · 2014 · 112 citations · Full text

Medicine, Oncology, Surgery +15

Studies on p53, BAX and Bcl-2 protein expression and microsatellite instability in stage III (UICC) colon cancer treated by adjuvant chemotherapy: major prognostic impact of proapoptotic BAX

Oliver Nehls, Tabitha Okech, C-J Hsieh et al. · British Journal of Cancer · 2007 · 71 citations · Full text

Medicine, Genetics, Oncology +17

Oxaliplatin, fluorouracil and leucovorin for advanced biliary system adenocarcinomas: a prospective phase II trial

Oliver Nehls, Bodo Klump, Hendrik‐Tobias Arkenau et al. · British Journal of Cancer · 2002 · 64 citations · Full text

Medicine, Oncology, Pharmacology +11

Signet Ring Cell Carcinoma of the Stomach Is Significantly Associated with Poor Prognosis and Diffuse Gastric Cancer (Lauren’s): Single-Center Experience of 160 Cases

Holger G. Hass, Ute Smith, Christina Jäger et al. · Onkologie · 2011 · 56 citations

Medicine, Oncology, Pathology +17